We are live on
!
Find out more
CL
Chubb Ltd Portfolio holdings
AUM
$29.9M
1-Year Est. Return
48.89%
This Fund
S&P 500
This Quarter
Est. Return
+7%
1 Year Est. Return
-48.89%
3 Year Est. Return
-64.23%
5 Year Est. Return
+404.81%
10 Year Est. Return
–
AUM
$151M
AUM Growth
-$87.1M
(-37%)
Cap. Flow
-$96.1M
Cap. Flow
% of AUM
-63.69%
Top 10 Holdings %
Top 10 Hldgs %
99.49%
Holding
21
New
–
Increased
1
Reduced
2
Closed
7
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NewtekOne
NEWT
|
+$3.42K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Morgan Stanley
MS
|
+$23.2M |
| 2 |
JPMorgan Chase
JPM
|
+$20.8M |
| 3 |
Archer Daniels Midland
ADM
|
+$20.6M |
| 4 |
AstraZeneca
AZN
|
+$17.6M |
| 5 |
Ericsson
ERIC
|
+$11.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 50.52% |
| 2 | Energy | 40.37% |
| 3 | Financials | 9.08% |
| 4 | Consumer Staples | 0.02% |
| 5 | Technology | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Merck
MRK
$318B
| $21.3M | 14.11% |
314,400
| – | – |
|
2
Sanofi
SNY
$104B
| $20.1M | 13.33% |
450,000
| – | – |
|
3
TotalEnergies
TTE
$190B
| $19.3M | 12.81% |
27,487,500
| – | – |
|
4
BP
BP
$107B
| $18.4M | 12.22% |
418,944
-6,042
| -1% | -$253K |
|
5
Pfizer
PFE
$153B
| $17.6M | 11.69% |
421,600
| – | – |
|
6
GSK
GSK
$106B
| $16.1M | 10.65% |
320,000
| – | – |
|
|
RDS.A
7
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $13.6M | 9.03% |
200,000
| – | – |
|
8
Western Union
WU
$2.21B
| $13.3M | 8.85% |
700,000
| – | – |
|
9
Williams Companies
WMB
$86.1B
| $9.52M | 6.31% |
350,000
| – | – |
|
10
Alphatec Holdings
ATEC
$1.44B
| $742K | 0.49% |
220,301
-255,894
| -54% | -$807K |
|
11
PTC Therapeutics
PTCT
$6.12B
| $384K | 0.25% |
8,180
| – | – |
|
|
12
NewtekOne
NEWT
$391M
| $348K | 0.23% |
16,592
+156
| +0.9% | +$3.42K |
|
|
SSI
13
DELISTED
Stage Stores Inc
SSI
| $32K | 0.02% |
16,491
| – | – |
|
|
CYHHZ
14
DELISTED
Community Health Systems, Inc. Series A Contingent Value Rights
CYHHZ
| $12K | 0.01% |
2,000,000
| – | – |
|
|
15
Archer Daniels Midland
ADM
$36.9B
| – | – |
-450,000
| Closed | -$20.6M |
|
|
16
AstraZeneca
AZN
$250B
| – | – |
-250,000
| Closed | -$17.6M |
|
17
eGain
EGAN
$201M
| – | – |
-21,355
| Closed | -$322K |
|
|
18
Ericsson
ERIC
$33.3B
| – | – |
-1,500,000
| Closed | -$11.5M |
|
|
19
JPMorgan Chase
JPM
$950B
| – | – |
-200,000
| Closed | -$20.8M |
|
|
20
Morgan Stanley
MS
$340B
| – | – |
-490,472
| Closed | -$23.2M |
|
|
QHC
21
DELISTED
Quorum Health Corporation
QHC
| – | – |
-184,709
| Closed | -$923K |
|
Similar funds
ECM
LN
HSCM
VH
EGA
EOCM
AC
BGP
Chubb Ltd's Q3 2018 Portfolio in Review
As of Q3 2018, Chubb Ltd held 21 positions worth $151M, down 37% from $238M the previous quarter. Its ten largest holdings account for 99% of the portfolio.
Chubb Ltd withdrew a net $96.1M in Q3 2018, closing 7 positions and reducing 2 holdings. Its most notable exit was Morgan Stanley, an estimated $23.2M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 51% of assets, up from 37% a quarter earlier, followed by Energy and Financials.
Against the trend, Chubb Ltd added an estimated $3.42K to NewtekOne.
- Chubb Ltd added most to NewtekOne in Q3 2018, an estimated $3.42K increase.
- Chubb Ltd's biggest Q3 2018 reduction was Alphatec Holdings, cutting an estimated $807K.
- Chubb Ltd fully exited Morgan Stanley in Q3 2018, selling an estimated $23.2M.
- Chubb Ltd's ten largest holdings make up 99% of its $151M portfolio in Q3 2018.
- Chubb Ltd opened 0 new positions and closed 7 in Q3 2018.
- Chubb Ltd's portfolio value fell 37% quarter-over-quarter to $151M.
Based on Chubb Ltd's 13F filing for Q3 2018, filed 31 Oct 2018.